Cancer Treatment
Cancer Treatment - Related Videos
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
0 Views •
Cited by 27 •
2015
Pancreatic cancer stem cells (CSCs) can be expanded in vitro using the anchorage-independent sphere culture technique, which represents a powerful tool to study CSC biology and can serve as the first step to develop novel CSC-targeting therapies. Here the methodology for expanding, analyzing and targeting of pancreatic CSCs is provided.
02:56
Treatment Resistent Cancers
0 Views •
2023
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56
Treatment Resistant Cancers
0 Views •
2021
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
0 Views •
Cited by 2 •
2023
In diagnosing and treating locally advanced thyroid cancer, the application of computer-aided three-dimensional reconstruction can provide additional information regarding the tumor scope and anatomic characteristics, thereby assisting in risk assessment and surgical planning.
07:46
In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
0 Views •
Cited by 39 •
2010
Orthotopic animal models of ovarian cancer replicate better human disease and therefore enhance our understanding of cancer progression and tumor response to therapy. A mouse model receives an intrabursal injection of luciferase-expressing ovarian tumor cells. Treatment is administered via oral gavage. Tumor growth is monitored by in vivo imaging system.
FAQs
Each cancer treatment exploits a different biological vulnerability in malignant cells. Surgery removes tumor tissue directly, radiation damages cellular DNA, and chemotherapy interferes with cell division. Targeted drugs act on molecular signals that support cancer growth, while immunotherapies improve immune recognition. Comparing these mechanisms helps explain why tumor biology matters when choosing an approach.
Surgery and radiation primarily address tumor tissue through distinct physical or cellular effects: surgery removes the tissue, whereas radiation damages DNA. Chemotherapy instead disrupts cell division, which reflects a different biological strategy. These distinctions allow treatment approaches to be considered according to how a particular malignancy grows and responds.
Targeted drugs block molecular signals that cancer cells require for growth, whereas immunotherapies enhance the immune system's recognition of tumors. The first strategy focuses on a cancer-associated growth pathway; the second focuses on immune detection. This distinction helps biologists connect treatment effects with tumor signaling, immune interactions, and personalized therapeutic design.
Different treatment mechanisms do not eliminate the need to understand how cancer cells and patients respond. Resistance can limit the effectiveness of an approach, while side effects affect patient well-being and quality of life. Biology research therefore examines treatment responses to improve therapeutic precision and support more effective, tolerable care.
Individualized decisions consider tumor type, stage, genetic features, and the patient's overall health. These factors describe both the cancer's biological and clinical context and the person's capacity to receive treatment. Using them together helps care teams select strategies more precisely rather than applying one approach uniformly, which supports personalized care.
Biology research uses cancer treatment to connect cellular mechanisms with clinical goals. Investigators study how malignant cells grow, how therapies affect those processes, and why resistance or side effects arise. This knowledge supports development of more precise therapies, improves understanding of cancer biology, and contributes to treatment strategies aimed at survival and quality of life.